Author:
Wagner Norbert,Niehues Tim,Oommen Prasad Thomas
Publisher
Springer Berlin Heidelberg
Reference15 articles.
1. Beukelman T, Patkar NM, Saag KG, Tolleson-Rinehart S, Cron RQ, Dewitt EM, Ilowite NT, Kimura Y, Laxer RM, Lovell DJ, Martini A, Rabinovich CE, Ruperto N (2011) 2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features. Arthritis Care Res (Hoboken) 63:465–482
2. Cassidy JT, Petty RE (2002) Juvenile rheumatoid arthritis. In: Cassidy JT, Petty RE (Hrsg) Textbook of pediatric rheumatology, 4. Aufl. Saunders, Philadelphia, S 218–321
3. Dueckers G, Guellac N, Arbogast M, Dannecker G, Foeldvari I, Frosch M, Ganser G, Heiligenhaus A, Horneff G, Illhardt A, Kopp I, Krauspe R, Markus B, Michels H, Schneider M, Singendonk W, Sitter H, Spamer M, Wagner N, Niehues T (2012) Evidence and consensus based GKJR guidelines for the treatment of juvenile idiopathic arthritis. Clin Immunol 142(2):176–193
4. Eccleston C, Cooper TE, Fisher E et al (2017) Non-steroidal anti-inflammatory drugs (NSAIDs) for chronic non-cancer pain in children and adolescents. Cochrane Database Syst Rev 8:CD012537
5. Foeldvari I, Szer IS, Zemel LS et al (2009) A prospective study comparing celecoxib with naproxen in children with juvenile rheumatoid arthritis. J Rheumatol 36:174–182